- The LLY stock price is trading at $571.28.
- The company stock has declined by 0.76% since the last trading session.
- The company stock has been traded with a volume of 2.7420 $Million in the last trading day.
Eli Lilly and Company (NYSE: LLY) is an American pharmaceutical company founded by Eli Lilly in May 1876. The company deals in the sales and manufacture of pharmaceutical products.
Eli Lilly and Company (LLY) Stock: Financial Analysis
The Pharma industry has risen by 2.2% in the last seven days. In one year the industry has gained 1.9%. The analysts are forecasting the industry earnings to grow by 16% annually in the upcoming years.
The healthcare sector has also risen by 1.7% in the last seven days. In one year the sector has gained 6.5%. The analysts are forecasting the growth of the industry earnings by 17% annually in the upcoming years.
Revenue: The LLY’s revenue has been consistently growing in the last three years from $24.54 Billion in 2020 to $28.32 Billion in 2021 to $28.54 Billion in 2022. The TTM revenue for 2023 is running at $29.54 Billion which has also increased from the previous year’s revenue.
Gross Profit: The LLY’s gross profit has also increased over the last three years. The company’s gross profit increased from $19.06 Billion in 2020 to $21.01 billion in 2021 to $21.91 Billion in 2022. The current 2023 TTM gross profit is running at $22.95 billion which has also increased from the last year.
Net Income: In 2021, the LLY’s net income faced a decline of 9.88% in its net income where its net income decreased to $5.58 Billion from $6.19 Billion in 2020. However, the company managed to recover from the fall and generated a net income of $6.24 Billion in 2022. The current TTMnet income for 2023 is running at $6.50 Billion which shows the company has surpassed the previous year’s net income.
Return on investment: The company has a 20% above ROI ratio over the last three years from 2020 to 2023. Which is a good return percentage on the invested capital for the investors.
Return on Equity: The firm has 50% above ROE in the last three years. The above 40% ROE is considered a good ROE. It also shows that the company is better at converting its equity financing into profit.
Debt-to-equity ratio: The company has maintained a neutral debt-to-equity ratio which indicates that the company hasn’t faced any potential risk of solvency over the last three years.
Eli Lilly and Company (LLY) Stock: Technical Analysis
The company stock price has risen more than 90% since March 2023. Recently, the company stock has experienced a gap-up scenario and has created a time-high of $601.18 after consolidating in a narrow range of $547.26 to $556.52.
The LLY Stock price is currently falling after reaching its all-time high which could also be seen as a profit booking scenario. As long as the price is sustained above the $547.26 level the buyers would be seen in charge of the price and could again raise the price to $601.18. If the also breaks above its all-time high then it may rise up to its next possible resistance at $630.10.
However, for the price to be in bearish sentiment the price must have closed below the $547.26 level then it may fall to $505.54 and could also fill the gap.
Conclusion
Overall, Eli Lilly and Company (LLY) stock is bullish. The company’s financials are also strong. The presence of buyers can be seen in the price. As long as the price is trading above $547.26 it will be in bullish sentiment and can touch its all-time high again. If the also breaks above its all-time high then it may rise up to its next possible resistance at $630.10. However, for the price to be in bearish sentiment the price must have closed below the $547.26 level then it may fall to $505.54 and could also fill the gap.
Technical levels
Resistance levels: $601.18 and $630.10
Support levels: $547.26 and $505.54.
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational purposes only. They do not establish financial, investment, or other advice. Investing or trading comes with a risk of financial loss.
